0001209191-17-041260.txt : 20170621 0001209191-17-041260.hdr.sgml : 20170621 20170621185611 ACCESSION NUMBER: 0001209191-17-041260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170619 FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADURO BIOTECH, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 510-848-4400 MAIL ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ISAACS STEPHEN T CENTRAL INDEX KEY: 0001193201 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 17923755 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-19 0 0001435049 ADURO BIOTECH, INC. ADRO 0001193201 ISAACS STEPHEN T C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710 1 1 0 0 President and CEO Common Stock 2017-06-19 4 M 0 21461 0.52 A 125486 D Common Stock 2017-06-19 4 M 0 18539 0.52 A 144025 D Common Stock 2017-06-19 4 S 0 40000 10.5041 D 104025 D Common Stock 70657 I By Family Trust Stock Option (right to buy) 0.52 2017-06-19 4 M 0 21461 0.00 D 2021-10-24 Common Stock 21461 120977 D Stock Option (right to buy) 0.52 2017-06-19 4 M 0 18539 0.00 D 2021-10-24 Common Stock 18539 430804 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.375 to $10.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The shares are owned directly by the Isaacs-MacBride Family Trust UAD 03/09/01, for which the Reporting Person is a trustee. The shares subject to the Option are fully vested and immediately exercisable. /s/ Jennifer Lew, Attorney-in-Fact 2017-06-21